Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF) (SAMURAI-NVAF)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Kazunori Toyoda, Ministry of Health, Labour and Welfare, Japan Identifier:
First received: April 16, 2012
Last updated: August 31, 2015
Last verified: August 2015